July 24, 2014Zecotek Display Systems and the Institute of Chemical Physics Develop Metal Alloys for 3D Printing
March 29, 2011Joint Institute for Nuclear Research for CERN COMPASS Experiment to Use Solid-State Photo Detectors
February 10, 2010Prestigious University to use Zecotek's LFS Crystals for Next-Generation PET Program
April 15, 2009Zecotek Establishes Ongoing Relationship with CERN with Initial Order of MAPD photo detectors
March 03, 2009Zecotek Closes Financing and Receives Grant Money from the Gov't of Malaysia and Singapore
December 03, 2007Demonstration of 32 inch 3D Display and Insight Media to Advise with 3D Market Entry
Archive of News Releases
To access a complete listing of Zecotek's news releases click here: ...more
Imagining Division Market Opportunities
April 22, 2015
Zecotek Provides Corporate Update on Imaging Division
Singapore, April 22, 2015 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to provide shareholders with a corporate update on its path to commercialize its leading-edge photonics technologies. The Company was founded with the vision to grow shareholder value by commercializing photonic technologies that offer both superior performance and economic advantages over competing technologies. Recent developments in the imaging industry have brought the Company closer to realizing this vision with respect to its patented LFs scintillation crystals, solid-state MAPD photo detectors and associated imaging technologies.
There are three main sectors within the imaging industry which have now accepted and endorsed the advantages of Lutetium Oxide based scintillation crystals and recognize them as the crystals of choice.
Clinical Positron Emission Tomography (PET) Medical Scanners
Today, new PET technology requires denser, faster and brighter crystals. OEMs are looking to Lutetium Oxide based scintillation crystals, compact solid-state photo detectors and faster electronic readout systems for the next generation of PET scanners. Time of Flight configurations will allow for higher resolution, and silicon based solid-state photo detectors present the possibility of integrating PET and MRI technologies into a single scanning device. At the same time, major OEMs have recently opted to move away from the purchasing of individual components (crystals, detectors, electronics), and purchase fully integrated detector modules made of an array of crystals, an array of photo-detectors, readout electronics and a data acquisition board.
Zecotek’s strategic partner, Hamamatsu Photonics of Japan, has developed an integrated detector module and has demonstrated the module abilities to leading PET OEMs. The modules use Zecotek’s patented LFS crystal arrays, which represent approximately half of the value of the module.
In parallel, Zecotek has integrated its own high performance detector module (IDM) using its own high performance imaging components; LFS crystal arrays, MAPD photo-detector arrays, and fast electronics. The Company is targeting BRIC healthcare markets and local OEMs, and expects to demonstrate its first commercial IDM in 2015, with technology transfer to manufacture and sales in 2016. The first module is being tested by PET developers. The manufacture and sales of the IDM is anticipated to be done through the Company’s strategic partner Hamamatsu.
Pre-Clinical Pharmaceutical PET Scanners
High Energy Physics
The recent news at CERN has focused on the start-up of the LHC and the previous issues resolved by the lengthy upgrade. However, the news also spotlights the need for the LHC to use high performance detection components to achieve its future goals. This is significant positive news for Zecotek. Decisions, regarding which detector components will be used for various experiments, are still pending. No announcements have yet been made. However, Zecotek’s components are being used by a number of experiments remain a prime candidates for the large scale, extreme energy experiments. The management and scientific teams at Zecotek will continue to work with CERN and build on a significant existing relationship until the selection process is complete.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.